drugset
drugset / Trial / NCT04019015

Prehospital Kcentra for Hemorrhagic Shock

NCT04019015 ↗

Phase 2 Unknown 166 enrolled Oregon Health and Science University
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a pilot trial being performed to evaluate the feasibility, to include the ability of EMS to identify patients in shock and the ability to package, store, and administer Kcentra in the field.

Timeline

Start
2021-03-15
Primary completion
2024-12-31
Completion
2025-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Prothrombin Complex Concentrate Protein / enzyme biologic 2000 iu —
Subject Prothrombin Complex Concentrate Protein / enzyme biologic 3000 iu —

Indications

No indication recorded.